GlassScriptPhysician profile
Ajay Kumar Lodha
NPI 1548299670
$11,945.74
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $215.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $11,073.18 | 2019 | |
| Lilly USA, LLC | $168.76 | 2019-2020 | |
| Boston Scientific Corporation | $120.11 | 2020 | |
| Dexcom, INC. | $113.34 | 2019 | |
| Indivior INC. | $73.18 | 2019 | |
| Stryker Corporation | $71.43 | 2019 | |
| Merck Sharp & Dohme LLC | $64.48 | 2019 | |
| Genentech USA, INC. | $62.57 | 2019-2020 | |
| Radius Health, INC. | $48.67 | 2019-2020 | |
| Pfizer INC. | $44.51 | 2019-2020 | |
| Amarin Pharma, INC. | $40.45 | 2019 | |
| Sunovion Pharmaceuticals INC. | $21.79 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.65 | 2020 | |
| Gilead Sciences, INC. | $13.67 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.95 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Lodha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.